DE3764676D1 - Zellschutz. - Google Patents

Zellschutz.

Info

Publication number
DE3764676D1
DE3764676D1 DE8787302132T DE3764676T DE3764676D1 DE 3764676 D1 DE3764676 D1 DE 3764676D1 DE 8787302132 T DE8787302132 T DE 8787302132T DE 3764676 T DE3764676 T DE 3764676T DE 3764676 D1 DE3764676 D1 DE 3764676D1
Authority
DE
Germany
Prior art keywords
cell protection
cell
protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787302132T
Other languages
English (en)
Inventor
Donald H Namm
Thomas Spector
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868606283A external-priority patent/GB8606283D0/en
Priority claimed from GB868623835A external-priority patent/GB8623835D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3764676D1 publication Critical patent/DE3764676D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787302132T 1986-03-13 1987-03-12 Zellschutz. Expired - Fee Related DE3764676D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868606283A GB8606283D0 (en) 1986-03-13 1986-03-13 Cell protection
GB868623835A GB8623835D0 (en) 1986-10-03 1986-10-03 Cell protection

Publications (1)

Publication Number Publication Date
DE3764676D1 true DE3764676D1 (de) 1990-10-11

Family

ID=26290487

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19873707999 Withdrawn DE3707999A1 (de) 1986-03-13 1987-03-12 Verwendung von oxypurinol zur verminderung von zellschaeden
DE8787302132T Expired - Fee Related DE3764676D1 (de) 1986-03-13 1987-03-12 Zellschutz.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19873707999 Withdrawn DE3707999A1 (de) 1986-03-13 1987-03-12 Verwendung von oxypurinol zur verminderung von zellschaeden

Country Status (6)

Country Link
EP (1) EP0237348B1 (de)
AU (1) AU599085B2 (de)
CA (1) CA1284951C (de)
DE (2) DE3707999A1 (de)
GB (1) GB2187954B (de)
ZA (1) ZA871813B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839826A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht
DE3839839A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
US5430037A (en) * 1988-11-25 1995-07-04 Henning Berlin Gmbh Chemie -Und Pharmawerk Oxypurinol alkali and alkalane earth salts in amorphous or crystalline form as agents for treating hyperuricaemia and gout
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
DE3839825A1 (de) * 1988-11-25 1990-06-13 Henning Berlin Gmbh Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
FR2641465A1 (fr) * 1989-01-11 1990-07-13 Bouchara Sa Nouveau capteur de radicaux libres et les compositions pharmaceutiques en contenant
AT396427B (de) * 1989-12-28 1993-09-27 Biokinet Chem Lab Pharmazeutische verwendung eines oxipurinolsalzes
GB9424842D0 (en) * 1994-12-09 1995-02-08 British Tech Group Pharmaceutical compositions
WO2006083687A1 (en) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Crystal salt of xanthine oxidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans
CA1265052A (en) * 1984-08-08 1990-01-30 Stanley J. Sarnoff Absorption enhancing agents

Also Published As

Publication number Publication date
AU6997187A (en) 1987-09-17
EP0237348B1 (de) 1990-09-05
GB2187954B (en) 1990-05-02
GB8705881D0 (en) 1987-04-15
GB2187954A (en) 1987-09-23
AU599085B2 (en) 1990-07-12
ZA871813B (en) 1988-10-26
EP0237348A1 (de) 1987-09-16
DE3707999A1 (de) 1987-09-17
CA1284951C (en) 1991-06-18

Similar Documents

Publication Publication Date Title
FI875566A0 (fi) Elektrolytisk cell foer alkalimetallhydrosulfitloesningar.
FI861628A (fi) Elektrod foer elektrokemisk cell.
DE3765024D1 (de) Ueberlastungsschutz.
FI870082A0 (fi) Munstycksarrangemang i tvao delar foer skummedel.
FI870025A0 (fi) Foerbaettringar i en kalcineringsapparat.
FI883527A0 (fi) Elektrolytisk cell.
DE3764676D1 (de) Zellschutz.
FI850441L (fi) Elektrolytisk cell.
FI861940A (fi) Stoedanordning foer nackstycket i en borrmaskin.
DE68915211D1 (de) Standardzelle.
NO853986L (no) Beskyttelsesanordning.
DE3784601D1 (de) Schmelzsicherung.
FI861927A0 (fi) Laosmekanism foer styranordningen i en elbrytare.
NO872954D0 (no) Hoeyspennings-halvledervern.
SE8604905D0 (sv) Storskyddsanordning
IT1213361B (it) Custodia salvacasco.
IT8623421V0 (it) Custodia salvacasco.
IT8623359V0 (it) Custodia salvacasco.
NO841659L (no) Sikringsanordning.
NO882265D0 (no) Overbelastningvern.
FI863307A0 (fi) Elektronisk felstroem- och skyddskrets i en vaermekabel.
FI862410A0 (fi) Oevertrycksventil i en rekombinationsackumulator.
FI862926A (fi) Faestunderlagsdel foer sjaelvhaeftande skylt i en pappersbanarulle foer automatiserade foerpackningslinjer foer tidningspapperrullar.
FI862991A (fi) Skaerelement i graesklippningsmaskin.
FI861925A0 (fi) Arrangemang foer en haolrotor i en barkningsmaskin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee